RxDoctor Payments Data

Ana Duarte, MD

Dermatology · Miami, FLNPI 1861462806

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $84,842 of the $106,894 with a category attached, or 79.4%. 32 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 52.8% of the total. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$106,894in general payments, 2019–2025

Across 443 payments — averaging $241.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$56K
  • Sanofi$24K
  • Pfizer$11K
  • Galderma Laboratories, L.p.$10K
  • LEO Pharma Inc.$2K
  • AbbVie$824
  • plus $3K from 26 others
$401,156in research payments, 2019–2025

Across 54 payments — averaging $7428.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$171K
  • UCB SA$82K
  • Incyte Corporation$64K
  • Novartis$62K
  • Sanofi US Services Inc.$12K
  • Aclaris Therapeutics, Inc.$10K

What the payments were for

  • Consulting fees$9,0208%
  • Speaking & faculty fees$84,84279%
  • Travel & lodging$2,3932%
  • Food & beverage$10,44510%
  • Education$1940%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$106,894 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$31,044
Medicare patients
94
Services billed
595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$299,719
Clobetasol Propionate24$2,376
Fluorouracil31$2,352
Ketoconazole154$1,967
Metronidazole18$1,262
Mometasone Furoate57$831
Clindamycin Phosphate22$816
Triamcinolone Acetonide66$720
Ciclopirox35$602
Nystatin26$285
Fluticasone Propionate13$219
Hydrocortisone12$184
Mupirocin29$137
Doxycycline Hyclate13$109
Ammonium Lactate13$84

Paid to pharmacies, not to this prescriber.

Other dermatology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →